MERCK, S.L. secures contract for Pharmaceutical products - Supply of active ingredient medications: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Health Care Management of Melilla

Spain, Aug. 31 -- Spain based MERCK, S.L. has secured contract from Gerencia de Atencion Sanitaria de Melilla - Instituto Nacional de Gestion Sanitaria for Pharmaceutical products - Supply of active ingredient medications: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Health Care Management of Melilla . The value of the contract is worth 104482.45 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....